Related Experiment Video
Updated: Jun 6, 2026

Isolation of Human Atrial Myocytes for Simultaneous Measurements of Ca2+ Transients and Membrane Currents
Published on: July 3, 2013
Alterations of atrial Ca(2+) handling as cause and consequence of atrial fibrillation
Maura Greiser1, W Jonathan Lederer, Ulrich Schotten
1Department of Physiology, Maastricht University, Maastricht, The Netherlands.
Insights
Atrial fibrillation (AF) involves complex calcium handling issues. Understanding these changes, both before and after AF onset, is key to developing targeted treatments for this common heart rhythm disorder.
Area of Science:
- Cardiology
- Electrophysiology
- Molecular Biology
Background:
- Atrial fibrillation (AF) is the most common sustained arrhythmia and a major risk factor for stroke.
- Current treatments for AF are challenging, necessitating novel therapeutic strategies.
- Altered intracellular calcium (Ca2+) handling is a critical aspect of AF pathophysiology.
Purpose of the Study:
- To review and critique the role of altered intracellular Ca2+ handling in AF pathophysiology.
- To differentiate Ca2+ handling changes preceding AF onset from those developing after AF onset.
- To examine the contribution of Ca2+ handling to excitation-transcription coupling, atrial contractile dysfunction, and arrhythmogenicity.
Main Methods:
- Literature review and critical analysis of existing research on intracellular Ca2+ handling in AF.
- Focus on the distinct roles of Ca2+ dysregulation in pre-AF conditions versus established AF.
- Examination of Ca2+-dependent signaling pathways, contractile function, and arrhythmogenesis.
Main Results:
- Intracellular Ca2+ handling undergoes significant remodeling in AF due to increased atrial activation and Ca2+ overload.
- Pre-AF Ca2+ homeostasis alterations in predisposing conditions differ from those post-AF onset.
- Altered Ca2+ handling contributes to excitation-transcription coupling, atrial dysfunction, and increased arrhythmogenicity.
Conclusions:
- Targeted therapies addressing specific aspects of altered intracellular Ca2+ handling hold promise for treating different types of AF.
- Distinguishing between pre-AF and post-AF Ca2+ remodeling is crucial for developing effective, individualized treatments.
- Further research into Ca2+-dependent mechanisms is essential for advancing AF management and reducing stroke risk.
Abstract:
Atrial fibrillation (AF) is the most prevalent sustained arrhythmia. As the most important risk factor for embolic stroke, AF is associated with a high morbidity and mortality. Despite decades of research, successful (pharmacological and interventional) 'ablation' of the arrhythmia remains challenging. AF is characterized by a diverse aetiology, including heart failure, hypertension, and valvular disease. Based on this understanding, new treatment strategies that are specifically tailored to the underlying pathophysiology of a certain 'type' of AF are being developed. One important aspect of AF pathophysiology is altered intracellular Ca(2+) handling. Due to the increase in the atrial activation rate and the subsequent initial [Ca(2+)](i) overload, AF induces 'remodelling' of intracellular Ca(2+) handling. Current research focuses on unravelling the contribution of altered intracellular Ca(2+) handling to different types of AF. More specifically, changes in intracellular Ca(2+) homeostasis preceding the onset of AF, in conditions which predispose to AF (e.g. heart failure), appear to be different from changes in Ca(2+) handling developing after the onset of AF. Here we review and critique altered intracellular Ca(2+) handling and its contribution to three specific aspects of AF pathophysiology, (i) excitation-transcription coupling and Ca(2+)-dependent signalling pathways, (ii) atrial contractile dysfunction, and (iii) arrhythmogenicity.
Related Concept Videos
Mechanism of Cardiac Arrhythmias
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias
Disturbances in Heart Rhythm
Arrhythmias are categorized by their speed, rhythm, and origin. A slow heart...
Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
Dysrhythmias II: Classification of Tachyarrhythmias
Dysrhythmias VI: Management of Dysrhythmias
